See where this fits in the roadmap
Core Facility for Optimal Management of Amyloid-beta Microdialysis Drug Discovery Program
Monday, 31 August 2009 12:28
In collaboration with an anonymous funder, Cure Alzheimer’s Fund is supporting development of a facility to measure the concentration of Amyloid-beta in real time in the brain of living, behaving mouse models that develop features of AD. The model enables screening for drugs that lower Amyloid-beta directly in the brain in relatively high throughput.
Dr. David Holtzman
Washington University
Dates Funded:
- May, 2007: $104,212
- April, 2008: $86,112
- March, 2009: $87,914
| < Prev | Next > |
|---|
